Cystagon

Product NDC
0378-9045
11-digit product format
003789045
Labeler code
0378
Product ID
0378-9045_29dfd298-96ed-4a5f-a573-b24f5ffa618b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
cysteamine bitartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
Mylan Pharmaceuticals Inc.
Application
NDA020392
Marketing category
NDA
Marketing start
2005-04-11
Substance
CYSTEAMINE BITARTRATE
Active strength
150 mg/1
Pharmacologic classes
Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020392-001CYSTAGONCYSTEAMINE BITARTRATEEQ 50MG BASECAPSULE / ORALRLD1994-08-15
N020392-002CYSTAGONCYSTEAMINE BITARTRATEEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15caaa826d4ba7…
2026-08-18 06:07:402026-07N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-1531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-1531067a03dcf5…
2025-08-23 18:47 UTC2025-08N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-156a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-1503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-152680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-155bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15d06236e962d9…
2024-10-29 15:01 UTC2024-10N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-1579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-151e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-158072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-158072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-155c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-155c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-155d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-155d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-154b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-154b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-1574a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-1574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020392-001CYSTAGONEQ 50MG BASECAPSULE / ORALRLD1994-08-15bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020392-002CYSTAGONEQ 150MG BASECAPSULE / ORALRLD, RS1994-08-15bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
Cystagon
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CYSTEAMINE BITARTRATE150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
QO84GZ3TSTInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
209788Internal RxNorm lookup
209789Internal RxNorm lookup
309636Internal RxNorm lookup
309637Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f495b76d-96c6-48e5-8fa3-30a4336628ebAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dd012da9-cd07-4d66-b6f1-ce3bdc2a3665Product name120210312
3d59dc1e-80a4-4b1f-b3e1-387c65c31efbProduct name320200619
a4fffefe-232a-3e06-c77d-1e6fdaec7d5eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0378-9045-05Cystagon500 in 1 BOTTLE, PLASTICCAPSULE50013

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0378-9045-01EA - Each0378-9045e2ba60f0-1a6a-4a0f-8126-592beb4b2ef012013-02-13
0378-9045-05EA - Each0378-904576ed0d4f-a82d-49ba-b2a4-b80f53ffa16612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CYSTEAMINE BITARTRATEACTIVE INGREDIENTQO84GZ3TSTCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
CYSTEAMINEACTIVE MOIETY5UX2SD1KE2CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
AMMONIAINACTIVE INGREDIENT5138Q19F1XCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
GELATININACTIVE INGREDIENT2G86QN327LCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPCYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0378-9045CYSTAGON (CYSTEAMINE BITARTRATE) CAPSULE [MYLAN PHARMACEUTICALS INC.]13Current NDC, Legacy NDC, 1 package rows20241215_f495b76d-96c6-48e5-8fa3-30a4336628eb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CystagonCYSTEAMINE BITARTRATEMylan Pharmaceuticals Inc.f495b76d-96c6-48e5-8fa3-30a4336628eb2021-08-16Warnings, Adverse reactionsExact identifier
application applno (NDA): 020392
application number: NDA020392
ndc (product): 0378-9045

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
209788Cystagon 150 MG Oral CapsulePSNf495b76d-96c6-48e5-8fa3-30a4336628eb13
209789Cystagon 50 MG Oral CapsulePSNf495b76d-96c6-48e5-8fa3-30a4336628eb13
309636cysteamine bitartrate 150 MG Oral CapsulePSNf495b76d-96c6-48e5-8fa3-30a4336628eb13
309637cysteamine bitartrate 50 MG Oral CapsulePSNf495b76d-96c6-48e5-8fa3-30a4336628eb13
209788cysteamine 150 MG Oral Capsule [Cystagon]SBDf495b76d-96c6-48e5-8fa3-30a4336628eb13
209789cysteamine 50 MG Oral Capsule [Cystagon]SBDf495b76d-96c6-48e5-8fa3-30a4336628eb13
309636cysteamine 150 MG Oral CapsuleSCDf495b76d-96c6-48e5-8fa3-30a4336628eb13
309637cysteamine 50 MG Oral CapsuleSCDf495b76d-96c6-48e5-8fa3-30a4336628eb13
209788Cystagon 150 MG Oral CapsuleSYf495b76d-96c6-48e5-8fa3-30a4336628eb13
209789Cystagon 50 MG Oral CapsuleSYf495b76d-96c6-48e5-8fa3-30a4336628eb13

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0378-9045-0500378904505500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9045-05) 500 capsule2005-04-112030-01-01NoNoCurrent